Clinical Trial Update: A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results update on concurrent VRP-HER2 vaccination and pembrolizumab for breast cancer, including the HER2-positive subset; results were posted on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• VRP-HER2 vaccine (VRP-HER2 vaccine)

Snippet

Sponsor: Herbert Lyerly | Conditions: Breast Cancer, HER2+ Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-12-11